DHG keeps throne by continuous innovation to create new values
November 26, 2019 | 15:00
Being the sole company to score a hat-trick at the 2019 Listed Enterprise Award with more excellent achievements than last year, DHG Pharmaceutical JSC (DHG) has grown from strength to strength, with deeper co-operation with Japanese strategic partner Taisho Pharmaceutical Co., Ltd.
Taisho still looking to increase stake in DHG
October 01, 2018 | 15:24
Taisho Group, one of the largest five pharmaceutical firms in Japan, expressed interest in buying an additional 2.3 per cent (3 million shares) in DHG.
Taisho offers to purchase DHG shares
July 17, 2018 | 14:04
Japanese pharmaceutical firm Taisho has offered to buy more than 9.23 million shares of DHG Pharmaceutical JSC (DHG), 7.06 per cent of DHG’s total shares.
Taisho inches towards domination at DHG
July 07, 2018 | 17:42
Taisho Group registered to buy an additional 7.06 per cent (9.2 million shares) in DHG as the next step in its plan to step-by-step acquire the drug maker.
DHG approved to abolish FOL
July 05, 2018 | 11:01
DHG has recently been approved to lift the foreign ownership limit (FOL) to 100 per cent, according to information published on its website.
Taisho Group increases holding in Hau Giang Pharmaceutical
June 05, 2018 | 12:46
Taisho Group expressed interest in buying an additional 650,000 shares to increase its holding in Hau Giang Pharmaceutical JSC (DHG) to 24.94 per cent.
DHG's profit falls in first quarter, challenges posed by FOL removal
April 30, 2018 | 12:20
Vietnam’s biggest publicly-traded drug maker Hau Giang Pharmaceutical JSC (DHG) saw a slight fall of 4.4 per cent on-year in its first quarter gross profit.
Mobile Version